Lucie Šrámková

Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group

Cornelia Eckert, Günter Henze, K. Seeger et al. · Journal of Clinical Oncology · 2013 · 166 citations

Medicine, Hematology, Oncology +17

Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort

Markéta Žaliová, Jan Stuchlý, Lucie Winkowska et al. · Haematologica · 2019 · 116 citations · Full text

Life Sciences, Genetics, Hematology +15

A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)

Erica Brivio, Franco Locatelli, Marta López‐Yurda et al. · Blood · 2020 · 90 citations · Full text

Medicine, Oncology, Pediatrics +17

Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia

Lucie Šrámková, Kateřina Mužíková, Eva Froňková et al. · Pediatric Blood & Cancer · 2006 · 89 citations

Medicine, Hematology, Pediatrics +17

Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG

Mareike Rasche, Martin Zimmermann, Emma Steidel et al. · Cancers · 2021 · 70 citations · Full text

Medicine, Hematology, Oncology +15